Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 25, Issue 3, Pages 279-293
Publisher
Bioscientifica
Online
2017-12-19
DOI
10.1530/erc-17-0450
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The induction of myeloma cell death and DNA damage by tetrac, a thyroid hormone derivative
- (2017) Keren Cohen et al. ENDOCRINE-RELATED CANCER
- HMGA2 promotes adipogenesis by activating C/EBPβ-mediated expression of PPARγ
- (2016) Yang Xi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Stem Cell FactorHMGA2Is Expressed in Non-HPV–Associated Head and Neck Squamous Cell Carcinoma and Predicts Patient Survival of Distinct Subsites
- (2016) Kathrin Günther et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Thyroid Function and Cancer Risk: The Rotterdam Study
- (2016) Samer R. Khan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Actions of l -thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells
- (2016) Hung-Yun Lin et al. STEROIDS
- The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status
- (2016) Yee-Shin Lee et al. STEROIDS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3
- (2015) Kathrin A Schmohl et al. ENDOCRINE-RELATED CANCER
- Abstract C96: Thyroid hormone induced Beta-catenin-dependent proliferation in colorectal cancer cells
- (2015) Hung-Yun Lin MOLECULAR CANCER THERAPEUTICS
- Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ERα status
- (2015) Yu-Tang Chin et al. Oncotarget
- HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression
- (2014) Yang Li et al. CANCER LETTERS
- Resveratrol and cancer: focus on in vivo evidence
- (2014) Lindsay G Carter et al. ENDOCRINE-RELATED CANCER
- Pharmacokinetics and Safety of Resveratrol Derivatives in Humans after Oral Administration of Melinjo (Gnetum gnemon L.) Seed Extract Powder
- (2014) Hiroko Tani et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- HMGA2 Is a Driver of Tumor Metastasis
- (2013) A. Morishita et al. CANCER RESEARCH
- WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer
- (2013) Peter Wend et al. EMBO Molecular Medicine
- Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective
- (2013) Lars C Moeller et al. ENDOCRINE-RELATED CANCER
- A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
- (2012) Rakesh Popat et al. BRITISH JOURNAL OF HAEMATOLOGY
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- HMGA2 Elicits EMT by Activating the Wnt/β-catenin Pathway in Gastric Cancer
- (2012) Lang Zha et al. DIGESTIVE DISEASES AND SCIENCES
- Cell cycle analysis of the CD133+and CD133-cells isolated from human colorectal cancer
- (2012) Marjan Gharagozloo et al. Journal of Cancer Research and Therapeutics
- Resveratrol and apoptosis
- (2011) Hung-Yun Lin et al. Annals of the New York Academy of Sciences
- Clinical trials of resveratrol
- (2011) Ketan R. Patel et al. Annals of the New York Academy of Sciences
- Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac)
- (2011) Anna B. Glinskii et al. CELL CYCLE
- Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers
- (2011) X. Wang et al. CLINICAL CANCER RESEARCH
- Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac)
- (2011) Takeshi Yoshida et al. EXPERIMENTAL EYE RESEARCH
- Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts
- (2011) Shaker A. Mousa et al. LUNG CANCER
- Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology
- (2011) Aleck H Hercbergs et al. Current Opinion in Endocrinology Diabetes and Obesity
- Pharmacodynamic Modeling of Anti-Cancer Activity of Tetraiodothyroacetic Acid in a Perfused Cell Culture System
- (2011) Hung-Yun Lin et al. PLoS Computational Biology
- Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites
- (2010) Juma Hoshino et al. JOURNAL OF MEDICINAL CHEMISTRY
- Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion
- (2009) Chen-Hsin Liao et al. ENDOCRINE-RELATED CANCER
- Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
- (2009) Luis Almeida et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Resveratrol bioavailability and toxicity in humans
- (2009) Charles-Henry Cottart et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent
- (2008) Abdelhadi Rebbaa et al. ANGIOGENESIS
- Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells
- (2008) Hung-Yun Lin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Metabolic Effects of Thyroid Hormone Derivatives
- (2008) Maria Moreno et al. THYROID
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started